Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperprolactinaemia and luteal insufficiency.

M Seppälä, T Ranta, E Hirvonen

    Lancet (London, England)
    |January 31, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Second Malignant Neoplasms Following Treatment for Childhood Cancer: A Population-Based Registry Study.

    Acta paediatrica (Oslo, Norway : 1992)·2026
    Same author

    Probability of live birth after IVF/ICSI treatments in female early onset cancer survivors: a Finnish population-based registry study.

    Human reproduction (Oxford, England)·2021
    Same author

    Fatal inhalation injury caused by airway fire during tracheostomy.

    Acta anaesthesiologica Scandinavica·2007
    Same author

    Supplemental 80% oxygen does not attenuate post-operative nausea and vomiting after breast surgery.

    Acta anaesthesiologica Scandinavica·2006
    Same author

    Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.

    Climacteric : the journal of the International Menopause Society·2002
    Same author

    Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding.

    Climacteric : the journal of the International Menopause Society·2002
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    High prolactin levels shorten the luteal phase and disrupt menstrual cycles. Bromocriptine can suppress prolactin, but effects are temporary, indicating prolactin

    Area of Science:

    • Reproductive Endocrinology
    • Hormonal Imbalances

    Background:

    • Hyperprolactinemia, characterized by elevated prolactin levels, can disrupt normal reproductive function.
    • The corpus luteum plays a crucial role in the luteal phase of the menstrual cycle, supporting potential pregnancy.

    Purpose of the Study:

    • To investigate the impact of hyperprolactinemia on luteal phase function.
    • To assess the efficacy of prolactin suppression using bromocriptine in managing hyperprolactinemia-related reproductive abnormalities.

    Main Methods:

    • Observation of ovulatory cycles in hyperprolactinemic women.
    • Monitoring of urinary pregnanediol excretion and plasma progesterone concentrations.
    • Assessment of symptom progression during recurrence of amenorrhea-galactorrhea syndrome.

    Related Experiment Videos

    Main Results:

    • Hyperprolactinemic women exhibited shorter luteal phases compared to normoprolactinemic women.
    • Reduced urinary pregnanediol and lower plasma progesterone levels were observed in hyperprolactinemic cycles.
    • Recurrence of amenorrhea-galactorrhea followed a specific order: increased prolactin, shorter luteal phase, galactorrhea, anovulation, and amenorrhea.

    Conclusions:

    • Prolactin directly interferes with corpus luteum function, leading to luteal phase defects.
    • Bromocriptine effectively suppresses prolactin and can temporarily alleviate associated reproductive issues.
    • The temporary nature of bromocriptine's effects highlights the persistent challenge of managing hyperprolactinemia.